chrisvoncsefalvay/vaers-outcomes huggingface dataset:
excess mercury in my body; Initial information received on 21-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who reported excess mercury in my body while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a non-serious event "excess mercury in my body" (blood mercury abnormal) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Flu Shot Fridays I took flu shots for over 11 years, a requirement to volunteer for hospice. Today I have excess mercury in my body. Never again will I volunteer for anything that requires any shot or vaccine".  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (excess mercury in my body).  At time of reporting, the outcome was Unknown for the event excess mercury in my body.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Severe, Systemic: Tingling (specify: facial area, extemities)-Severe, Systemic: Visual Changes/Disturbances-Severe, Additional Details: BP = 60/38, fainting but responsive, numbness & tingling in fingers and mouth, blurred vision
sweats; chills; body aches; fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), CHILLS (chills), MYALGIA (body aches) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweats), CHILLS (chills), MYALGIA (body aches) and FATIGUE (fatigue). At the time of the report, HYPERHIDROSIS (sweats), CHILLS (chills), MYALGIA (body aches) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No treatment medications were reported.
This case was reported by a physician via call center representative and described the occurrence of myalgia in a patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced myalgia, fatigue and fever. The patient was treated with medication unknown (Fluids) and Acetaminophen and Ibuprofen. On an unknown date, the outcome of the myalgia, fatigue and fever were recovered/resolved. It was unknown if the reporter considered the myalgia, fatigue and fever to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The physician administered the SHINGRIX vaccination and the patient had an adverse albeit expected reaction of myalgia, fatigue and fever that resolved in a few days with fluids, rest and acetaminophen and ibuprofen (no Emergency visit or hospitalization). No lot number or expiration date or patient details were provided.
Bumpy rash with itching to injection sites reported on 9/10/03. Tx'd with cutivate cream without relief. Continues with generalized red, bumpy rash to thighs and torso.
DEVELOPED BREATHING ISSUES; SHORTNESS OF BREATH AND LABORED BREATHING ON EXERTION, PATIENT LET IT GO UNTIL IT BECAME EXTREMELY PROBLEMATIC; This spontaneous report received from a patient concerned a 68 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: mild hypertension, and cholesterol, and other pre-existing medical conditions included: Patient was in reasonably good health. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced developed breathing issues, and shortness of breath and labored breathing on exertion, patient let it go until it became extremely problematic. Treatment medications (dates unspecified) included: salbutamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath and labored breathing on exertion, patient let it go until it became extremely problematic, and the outcome of developed breathing issues was not reported. This report was non-serious.
swollen area on right arm where vaccine was administered, patient went to her doctor 10/14/21 and the doctor called us to confirm which vaccine she had received
Starting in sept 2020 I had cramping in my lower back on Monday.  By Wednesday the burning sensation increased and wrapped around my abdomen.  Went to Dr and I was diagnosed w/ a urinary track infection and given medication for that but that didn't help.  The next day I went back to the Dr.  I was told again that it was a urinary tract infection and I was given a different medication.  The burning pain only increased as the week went on.  I went to a different dr and was diagnosed w/ shingles and received medication.  The pain steadily increased over the next few days until it began to subside.  I then developed a rash over my back and abdomen.  It subsided a little bit but I'm still experiencing occasional rash and itching.
suddenly lightheaded, dizzy, weak legs, slightly short of breath upon walking. approximately 2-3 hours then laid down for 6 hours. had excruciating headache. dizziness resolved but as of 4-21-21 headaches continue intermittently
Pt developed swelling limited to the left side of her tongue with erythema, difficulty speaking.  she took mortin and zyrtec, presented to the ED about 10 hours after symptoms started.  symptoms were improving at time of arrival.
nose-bleeds; was experiencing chills; has been tired; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose-bleeds), CHILLS (was experiencing chills) and FATIGUE (has been tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced EPISTAXIS (nose-bleeds), CHILLS (was experiencing chills) and FATIGUE (has been tired). At the time of the report, EPISTAXIS (nose-bleeds), CHILLS (was experiencing chills) and FATIGUE (has been tired) outcome was unknown. Not Provided          No relevant concomitant medications reported.  No treatment information was provided.
devel hives 1 1/2 hrs p/vax on 11MAR94; devel rash & pruritis all over body except face on 12MAR94; rash disappeared 12MAR94 around 4PM; started hydrocortisone per MD 11MAR94 @ 530PM;
CHILLS, SORE THROAT, NIGHT SWEATS, MUSCLE WEAKNESS.
Chest pain, hard to breathe and small bumps around my entire mouth.  Tried to take Benadryl to take the bumps away but it did not help. It went away on its own.
Information has been received from a licensed practical nurse concerning an approximately 5 year old patient who in approximately 2004 was vaccinated with a first dose of MMR II.  It was reported that the patient's mother thinks her child developed autism from the vaccine.  It was noted that the child received the vaccination when she was "around one years old."  Medical attention was sought, the office was contacted.  It was unspecified if lab studies were performed.  At the time of the report, the patient had not recovered.  There was no product quality complaint involved.  Upon internal review autism was considered an other important medical event.  No further information is available.
During physical therapy on got a sharp burning sensation down my neck. When I tried to make note of this for my physical therapist, I could not hold a pen to write. I went to the emergency room they ran a CT scan both with and without contrast, an MRI, an Echocardiogram, CBC all tests show I positive for Transient ischemic attack. I was started on a regimen of baby aspirin, increase my atorvastatin that I had started in October. I was advised to stop the hormone replacement therapy.
Edematous swelling in the right armpit extending into the right chest/peculiars area. Also noted swelling in the right posterior side of the chest. Tender to touch and tender with right arm movement.
Face rash, itchy for 2 days, (face and neck) Face warm to touch, Seen by NP no treatment
Approximately 14-15 hours after the vaccine, while asleep I developed rapid heart palpitations. It was so strong it woke me up around 2:20am. Unable to fall back to sleep I continued to lie in down. Around 8 hours later, it had slowed down a lot. This is when I checked my pulse with our machine  and it registered at 126 while resting. It was already much slower than during the night which I would guess the range to be 150-160.  In hindsight, I probably should have gone to the emergency but I was very tired and running a low grade temperature.
1/31/2019 C/O redness/swelling/induration 4 days post vaccination (R) arm PNEUMOVAX 23. 2nd revaccination approximately 75 years. 9 x 7 cm erythema 2 inches below injection site.
Sore and inflamed left arm and red rash. headache medium, fever 100.4 thru 100.8 for about 42 hours starting early Saturday morning after a Friday inoculation, and ending Sunday evening. Woke up Monday feeling well and no after-effects. Took some tylenol during the event.
Patient passed out (had syncope) a few minutes after she got the HPV shot. BP was normal, bld sugar 91, PR was initially 53 -> 58 -> 63. Pt made to lie down, rest, drink water & felt better later.
Multiple ulcers/canker sores on mouth, tongue and throat, soreness at injection site, painful swollen lymph node in left armpit.
Anterior upper arm swollen, tender to touch, central or erythema approx. 3 cm x 5.5 cm, warm to touch redness appears less intense now than when initially seen 2 hours ago. Painful from "shoulder to fingertips" cramping, uncomfortable, 8/10 at that time, no 4/10. Took Aleve at 0730 today. Has also been treating w ice pack with some relief.
Presents for progressively worsening SOB, fever, cough. Admit for afib RVR, COVID pneumonia, & acute resp failure w/hypoxemia. Tx: decadron, remdesivir, vit c, vit d, zinc. O2. Discharged to rehab.
9 days after the vaccine, the injection site became sore, swollen and red, about the size of a half dollar. Today, 11 days following vaccination, it is about the same, though it was bigger this morning. I am putting ice on it.
After receiving my 3rd dose of vaccine I experienced an out of cycle menstrual cycle, starting to mensrtrate the next day (8/20).  Since receiving the 3rd dose of vaccine all following menstrual cycles have happened earlier than normal. Covid Vaccine dose 1 was 3/23/21, dose 2 was 4/20/21, no side effects were observed  Previous menstrual cycles started on/around the 4th of each month until receiving the 3rd vaccine.
Dialysis pt recvd 5 doses of Engerix-B & was found to be a nonresponder; 26APR93 pt self dicontinued the dialysis & died on 20MAy03;
Patient received the vaccine around 10 am on 3-10-21. He mentioned to the vaccinator that he had a large anxiety of needles. After receiving the vaccine the patient went to the recovery area for the required 15 minutes. About 10 minutes later his breathing rapidly increased - eventually turning to large gasps of air. The patient then briefly passed out but then quickly woke up. He then started vomiting for the next 10 minutes. Eventually he recovered enough to walk with the help of his wife. The wife stated that he has had episodes like this from other vaccines and blood draws. He has never vomited from the episodes, however.
Neck pain Dx Myelopathy Eye pain change vision Dx. Optic Neuritis Devic's disease.
Lethargic, body aches all over body, pt. experienced TIA on 10/14/16.
CHEST PAIN; CHEST PAIN RADIATING TO STOMACH ON AND OFF; PAIN LIKE SENSITIVE TO TOUCH ON LOWER BACK OF LEGS BELOW KNEE (RIGHT LEG IS MORE SENSITIVE TO THE TOUCH THAN LEFT); This spontaneous report received from a patient concerned a 45 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient did not known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 13-APR-2021 for prophylactic vaccination. The batch number was not reported, per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 17-APR-2021, the subject experienced pain like sensitive to touch on lower back of legs below knee (right leg is more sensitive to the touch than left). On 20-APR-2021, the subject experienced chest pain. On 20-APR-2021, the subject experienced chest pain radiating to stomach on and off. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain like sensitive to touch on lower back of legs below knee (right leg is more sensitive to the touch than left), and chest pain, and the outcome of chest pain radiating to stomach on and off was not reported. This report was non-serious.
Shingrix administered to a 47YO; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 47-year-old male patient who received Herpes zoster (Shingrix) (batch number 252JX, expiry date 23rd September 2023) for prophylaxis.   On 26th July 2022, the patient received Shingrix (intramuscular). On 26th July 2022, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK Receipt Date: 10-OCT-2022 Reporter's Comment: The patient was immunocompetent. The reporter consented to follow up. Additional Supportive Information: The patient was administered Shingrix at inappropriate age, which led to inappropriate age at vaccine administration.
Event: Lethargy, fever, decreased urine output beginning a few hours after vaccination. Lumbar puncture and blood cultures revealing strep pneumoniae bacteremia and meningitis. Head CT revealing mastoiditis.  Treatment:   penicillin G IV total 14 days Outcome: Septicemia and meningitis resolved. However, residual mobility and balance issues.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: Patient came in to pick up prescription. Stated she had "covid arm". Observed swelling and redness of muscle area.  Patient states she had not reported it as she read is very common on people who received the covid vaccine.  I explained that it needed to be reported as a severe reaction.
Hives/rashes covering entire body began 10 days after receiving booster dose.  Patient is taking Zyrtec to control hives.
Begin to have massive headaches and loss of appetite. My voice started to sound raspy. By December of that year 2021, I wound up in the hospital:     I was diagnose with Vasculitis, Kidney failure, loss sight to my right eye, neuropathy on 2 fingers of my right hand,  and  peripheral neuropathy on the balls of my feet.  A hematologist, Dr. had me do a lab that revealed the presence of a particular gene mutation called: MTHFR MUTATION (HOMOZYGOUS), a blood clotting gene as I understand it.
Injection at 11am on 3/9/21. Typical soreness at injection site. At 6pm, the same day, headache, fatigue, chills begin. Fever reaches 102 overnight. Fever down to 100 on 3/10/21. Today is 3/13/21, 4 days after injection, fever is still at 100. Extreme fatigue. Cannot do any daily activities. Tiredness, headache will not go away. Advil/Tylenol will not lower temp.
swimmers ear; brain felt itchy; fatigue; headache; received second vaccine in left thigh; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), OTITIS EXTERNA (swimmers ear), PRURITUS (brain felt itchy), FATIGUE (fatigue) and HEADACHE (headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Muscle disorder NOS (muscle problems) and Nervous system disorder NOS (Nerve problems).   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced DIARRHOEA (diarrhea), FATIGUE (fatigue), HEADACHE (headache) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (received second vaccine in left thigh). On an unknown date, the patient experienced OTITIS EXTERNA (swimmers ear) and PRURITUS (brain felt itchy). On 08-May-2021, DIARRHOEA (diarrhea), FATIGUE (fatigue), HEADACHE (headache) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (received second vaccine in left thigh) had resolved. At the time of the report, OTITIS EXTERNA (swimmers ear) and PRURITUS (brain felt itchy) outcome was unknown.            No Concomitant medications were reported No treatment medications were reported   This case was linked to MOD-2021-271787 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Non-significant follow up appended. no new information received.
Hypotension in the 70s/40s despite IV fluid replenishment.   Per our MD DC/transfer note:  PEG displacement, ongoing sepsis, hypoglycemia.  Assess for other reason for hypotension including sepsis, cardiogenic shock, acute abdominal processes. patient was transferred to the Hospital ER where she expired
Tdap vaccination administered on 6/11/2008. Client called the HD on 6/12/2008 with c/o facial pain, sinusitis, headache and mild tenderness and swelling at the site of the injection in the right deltoid region. Client had called her physician as she also has food allergies and she felt her reactions were the same as when she has had an allergic food reaction. She was advised by her physician to rest until the symptoms resolved. Later that evening on 6/12/2008 she experienced Nausea and vomiting which resided by the late afternoon of 6/13/2008. by 6/14/2008 all her symptoms has resided and she felt back to normal. The initial symptoms began aprox. 23 hours after receiving the Tdap vaccine and were resolved in 3 days. The client had no known allergies to the components of the Tdap vaccine prior to her vaccination and had received both pertussis and tetanus and diptheria vaccinations in her past history. No treatment was administered by her physician. HD Health Officer was notified and the follow up plan included- a return call to the client for assessment of ther resolution of symptoms and a VAERS report was to be filed.
Had headache evening of flu immunization (10-01-2010) which continued for 3 days-states headaches responded to Advil and finally went away.  On November 5th, 2010 she woke up and noticed right facial drooping of Right eye and mouth.  Went to emergency room and was diagnosed with Bells Palsy. Treated with course of Prednisone.  She followed up with her Primary Care MD and was referred to a neurologist who began her on a second treatment of prednisone week of December 6th. Symptoms slowly resolving
Today during an encouter, patient mentioned she had muscle pain in arm ever since her shingles vaccine 1 year ago. I recommended she contact her PCP
10A received vaccine; 2 PM reports flushing, dizzy, eyes burning, nauseated, flash also upper back. Benadryl 25 mg PO given at 2:15 PM when present.
Fatigue, chills 6 hours after injection. By 9 hours after injection I had a fever of 102.7, which was sustained for several hours and accompanied by fatigue, weakness and headache. 24 hours after injection, fever is down to 99 and accompanied by body aches. Fatigue is improved.
site of the injection was red; Red rash; site of the injection irritated; Warm to the touch; This case was reported by a pharmacist via call center representative and described the occurrence of injection site irritation in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number HB2B2, expiry date 13th April 2020) for prophylaxis.   On 2nd May 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In May 2019, less than a week after receiving Shingrix, the patient experienced injection site irritation, injection site warmth, injection site erythema and injection site rash. On an unknown date, the outcome of the injection site irritation and injection site warmth were recovered/resolved and the outcome of the injection site erythema and injection site rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site irritation, injection site warmth, injection site erythema and injection site rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient for the first 36 hours experienced red, warm to the touch, and irritated. The events went away and patient went to the beach and the same area of the injection was exposed to the sun for 12 hours and the red rash reappeared. The initial reaction lasted for a day and a half and then recovered. No further information provided regarding timing of events.
Anthrax injection site-rt upper arm is hot to touch, erythema present, center of reddened area hard-area is 3 x 3 1/2 cm.
VAR. admin - SQ in LA 11/08/10. Pt called c/o increased redness (approximately 4cm in diameter) increased pain over site. 11/10/10 advised to go to PMD to r/o cellulitis. Tx'ed by Prime Care BACTRIM DS 1 Q12 hours  x 10days (+) cellulitis.
CASE IS SYMPTOMATIC, RUNNING NOSE, NO TASTE OR SMELL AND COUGH, ONSET DATE: 8/12/2021
Expired Boostrix administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 11-year-old female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On 3rd February 2023, the patient received Boostrix. On 3rd February 2023, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 10-FEB-2023 Reporter's Comment: The reporter was a other healthcare professional who is manager at health facility. The reporter reported that on 3rd February 2023 the female patient received an expired dose of Boostrix vaccine. Additional supportive information: The patient received a Boostrix which was already expired, which led to expired vaccine used.